Bottom line
SWISX vs GIIAX: the short answer
SWISX (Schwab International Index Fund) and GIIAX (Nationwide International Index Fund) share a meaningful slice of their top holdings — about 79% by weight.
SWISX is cheaper at 0.06% vs 0.69% — a difference of $63 a year per $10,000 invested.
Over five years, SWISX returned +9.0% a year vs +7.1% for GIIAX.
GIIAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
SWISX vs GIIAX side by side
| SWISX | GIIAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Schwab | Nationwide |
| Category | International Stock | International Stock |
| Expense ratio | 0.06% | 0.69% |
| Annual cost per $10k | $6 | $69 |
| 10-yr cost on $10k (prospectus) | $77 | $1,457 |
| Max front load | — | 5.75% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +31.6% | +23.5% |
| 5-yr return (annualized) | +9.0% | +7.1% |
| 10-yr return (annualized) | +8.3% | +7.1% |
| Best quarter | +18.2% | +18.3% |
| Worst quarter | −23.2% | −22.8% |
| Net assets (fund) | $13.6B | $910.2M |
| Number of holdings | 697 | 693 |
| Portfolio turnover | 1% | 13% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SWISX | GIIAX | Difference |
|---|---|---|---|
| 2025 | +31.6% | +31.0% | +0.5% |
| 2024 | +3.5% | +2.9% | +0.6% |
| 2023 | +18.2% | +17.0% | +1.2% |
| 2022 | −14.3% | −14.4% | +0.2% |
| 2021 | +11.3% | +10.6% | +0.7% |
| 2020 | +8.1% | +7.3% | +0.9% |
| 2019 | +21.9% | +21.5% | +0.3% |
| 2018 | −13.3% | −14.1% | +0.8% |
| 2017 | +25.3% | +24.7% | +0.5% |
| 2016 | +1.1% | +0.6% | +0.5% |
Source: Fund prospectus bar charts
Holdings overlap
21 of SWISX's top 25 holdings also appear in GIIAX's top 25.
| Holding | SWISX | GIIAX |
|---|---|---|
| ASML Holding NV | 2.58% | 2.86% |
| Roche Holding AG | 1.48% | 1.38% |
| HSBC Holdings PLC | 1.41% | 1.66% |
| AstraZeneca PLC | 1.34% | 1.16% |
| Novartis AG | 1.30% | 1.29% |
| Nestle SA | 1.14% | 1.16% |
| Siemens AG | 1.06% | 1.09% |
| Shell PLC | 1.03% | 1.16% |
| Toyota Motor Corp | 0.99% | 0.81% |
| Sap Se | 0.96% | 0.86% |
| Mitsubishi UFJ Financial Group Inc | 0.96% | 1.08% |
| Novo Nordisk A/S | 0.89% | 0.68% |
| Banco Santander SA | 0.88% | 0.91% |
| BHP Group Ltd | 0.81% | 0.97% |
| Commonwealth Bank of Australia | 0.80% | 0.94% |
Source: SEC Form N-PORT
SWISX top 10
- ASML Holding NV — 2.58%
- Roche Holding AG — 1.48%
- HSBC Holdings PLC — 1.41%
- AstraZeneca PLC — 1.34%
- Novartis AG — 1.30%
- Nestle SA — 1.14%
- Siemens AG — 1.06%
- Shell PLC — 1.03%
- Toyota Motor Corp — 0.99%
- Sap Se — 0.96%
GIIAX top 10
- ASML Holding NV — 2.86%
- HSBC Holdings plc — 1.66%
- Roche Holding AG — 1.38%
- Novartis AG — 1.29%
- AstraZeneca plc — 1.16%
- Shell plc — 1.16%
- Nestle SA — 1.16%
- Siemens AG — 1.09%
- Mitsubishi UFJ Financial Group, Inc. — 1.08%
- BHP Group Ltd. — 0.97%
FAQ
What is the difference between SWISX and GIIAX?
Which is cheaper, SWISX or GIIAX?
Should I own both SWISX and GIIAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.